IART Stock Analysis: Buy, Sell, or Hold?
IART - Integra LifeSciences Holdings
$13.56
-0.44 (-3.14%)
▼
5d:
+28.65%
30d:
+40.96%
90d:
+24.63%
WAIT
LOW Confidence
Analysis Updated: May 7, 2026 12:00 AM ET
Earnings: May 05, 2026
0d
Get Alerted When IART Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
⏸️ WAIT FOR BETTER ENTRY: IART is 14.6% above its trading range ($11.83). Market expects 4.6% annual growth, but current price leaves little margin for error. While momentum could continue, risk/reward favors waiting for a pullback.
⏸️ WAIT FOR BETTER ENTRY: IART is 14.6% above its trading range ($11.83). Market expects 4.6% annual growth, but current price leaves little margin for error. While momentum could continue, risk/reward favors waiting for a pullback.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$16.00
Based on 6.3% avg growth
INTRINSIC VALUE TODAY
$9.93
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 4.6x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: IART is currently trading at $13.56, which is considered extended relative to its 30-day fair value range of $9.44 to $11.83. From a valuation perspective, the stock is trading at a premium (Forward PE: 5.3) compared to its historical average (4.6). At these levels, the market is pricing in 4.6% annual earnings growth. This is a high bar to clear, indicating the stock may be priced for perfection.
Technical Outlook: Technically, IART is in a downtrend. Immediate support is located at $10.01, while resistance sits at $14.38. Short-term momentum is weak, with the stock down 3.1% recently.
Market Sentiment: IART has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $15.67 (+15.5%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, IART is in a downtrend. Immediate support is located at $10.01, while resistance sits at $14.38. Short-term momentum is weak, with the stock down 3.1% recently.
Market Sentiment: IART has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $15.67 (+15.5%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$9.44 -
$11.83
Company Quality Score
50/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
40.5%
All Signals
- BEARISH: Price significantly overextended (+14.6% above its trading range)
- BULLISH: Strong technical setup (60/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-3.1%)
- BULLISH: Trading below Wall St target ($15.67)
- BEARISH: Market expects 4.6% growth - appears too optimistic based on history
Trading Range Analysis
30-Day Trading Range
$9.44 -
$11.83
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$10.01
Resistance Level
$14.39
Current Trend
Downtrend
Technical data as of
May 7, 2026
Fundamental Context
Forward P/E (Next Year Est.)
5.29
Wall Street Target
$15.67
(+15.5%)
Revenue Growth (YoY)
2.4%
Earnings Growth (YoY)
0.4%
Profit Margin
-30.1%
Valuation Premium vs History
+4.6% premium
PE vs Historical
5.3 vs 4.6
STRETCHED
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+4.6%
(market-implied from PE analysis)
1-Year Target
$14.18
(+5%)
2-Year Target
$14.84
(+9%)
3-Year Target
$15.52
(+14%)
3-Yr Target (if PE normalizes)
(PE: 5→5)
PE COMPRESSION
$13.50
(-1%)
Earnings growth offset by PE compression
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 21.9, Growth: 8.6%)
$72.06
(+431%)
Base:
(SPY PE: 5.3, Growth: 8.6%)
$17.37
(+28%)
Bear:
(PE: 4.5, Growth: 8.6%)
$14.77
(+9%)
Share & Embed Analysis
Last updated: May 08, 2026 9:17 AM ET
Data refreshes hourly during market hours. Next update: 10:17 AM
Data refreshes hourly during market hours. Next update: 10:17 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is IART showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BSX
Boston Scientific Corp |
STRONG BUY
34 analysts |
$85 | 57 HOLD |
|
DXCM
DexCom Inc |
STRONG BUY
26 analysts |
$84 | 58 HOLD |
|
MDT
Medtronic PLC |
BUY
32 analysts |
$108 | 58 HOLD |
|
EW
Edwards Lifesciences Corp |
HOLD
32 analysts |
$97 | 63 BUY |
|
ZBH
Zimmer Biomet Holdings I… |
HOLD
29 analysts |
$99 | 56 HOLD |
